 |
|
|
|
|
|
BSc | FFPM
FRCP | MD(Lond)
DipPharmMedRCP
CBiol | FIBiol |
|
 From 1994 to 1997, Tony Fox was Vice-President for Drug Development
 and Regulatory Affairs at Cypros Pharmaceuticals in Carlsbad, California,
where he led two drugs from IND to Phase III.
Prior positions include Director of Cardiovascular and Anaesthesia clinical
research at Glaxo, where he led the US sumatriptan group and chaired the
international remifentanil project (1990-1994).
Group Leader with Procter and Gamble (phase I and II clinical trials and
medical affairs).
Tony Fox obtained three degrees from the University of London: BSc major
in pharmacology (first class honours, 1977), his medical degree (1980) and
a doctorate in pharmacology (1988). He is a Fellow of the Faculty and holds
the Diploma in Pharmaceutical Medicine (Royal Colleges of Physicians, UK).
Tony Fox co-edited “Treating the Headache Patient” with Roger Cady, and
was on the editorial team of the major textbook “Practice and Principles of
Pharmaceutical Medicine” which is going into its third edition.
|
|
|
|
|
|
FGK Representative
Service GmbH
Heimeranstrasse 35
80339 Munich
Germany
T | +49 (0) 89 893 119-22
F | +49 (0) 89 893 119-20
www.fgk-rs.com
info@fgk-rs.com |
|
|
|
